Results

Total Results: 4,884 records

Showing results for "end stage renal".

4781. 8 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4782. 8 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4783. 8 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4784. 8 (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
      November 01, 2008 - outcomes data, including data that showed no difference in gastrointestinal adverse events at the end … Development of instruments for assessing risk of bias specifically in studies of harms is still in an early stage … Adverse Effects of Cyclooxygenase 2 Inhibitors on Renal and Arrhythmia Events: Meta-analysis of

4785. Assessing the Health and Welfare of the HCBS Population | Agency for Healthcare Research and Quality
      www.qualitymeasures.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/findings/tab3b.html
      December 01, 2012 - Multiple Chronic Conditions On-Time Quality of Life Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures

4786. Abnormal-Uterine-Bleeding Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
      March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid

4787. Abnormal-Uterine-Bleeding Executive (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
      March 01, 2013 - • Who are healthy, and without renal impairment, hepatic impairment, intestinal disease, thyroid

4788. Disposition of Comments: Technical Brief 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
      November 03, 2020 - factors associated with opioid use, and opioid-related harms and adverse outcomes are included at the end … Next Steps Several future areas of research are identified at the end of each section throughout the … assume long-term opioid use is automatically bad, and because policymakers do not always read to the end … I am now at Stage II Renal Failure. … of ersatz expected utility model you embrace- but you lack the honesty to state clearly what your end

4789. Disposition of Comments: Technical Brief 37 Prevention, Diagnosis, and Management of Opioids, Opioid Misuse, and Opioid Use Disorder in Older Adults (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/tech-brief-37-opiod-use-adults-comments.pdf
      November 03, 2020 - factors associated with opioid use, and opioid-related harms and adverse outcomes are included at the end … Next Steps Several future areas of research are identified at the end of each section throughout the … assume long-term opioid use is automatically bad, and because policymakers do not always read to the end … I am now at Stage II Renal Failure. … of ersatz expected utility model you embrace- but you lack the honesty to state clearly what your end

4790. AHRQ Multiple Chronic Conditions Research Summit: Speaker Biosketches | Agency for Healthcare Research and Quality
      www.qualitymeasures.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
      November 01, 2021 - Webinar - November 18, 2021 On-Time Quality of Life Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures … Services, a health services researcher in the Knowledge and Evaluation Research (KER) Unit and the Late Stage … former Chair of the Public Policy Committee and a member of the Board of Directors of the Mid-Atlantic Renal … Medicaid Services Evidence Advisory Committee, was appointed to the Michigan Governor’s Commission on End

4791. AHRQ Multiple Chronic Conditions Research Summit: Speaker Biosketches | Agency for Healthcare Research and Quality
      ce.effectivehealthcare.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
      November 01, 2021 - Webinar - November 18, 2021 On-Time Quality of Life Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures … Services, a health services researcher in the Knowledge and Evaluation Research (KER) Unit and the Late Stage … former Chair of the Public Policy Committee and a member of the Board of Directors of the Mid-Atlantic Renal … Medicaid Services Evidence Advisory Committee, was appointed to the Michigan Governor’s Commission on End

4792. 3. Which fall prevention practices do you want to use? | Agency for Healthcare Research and Quality
      pbrn.ahrq.gov/patient-safety/settings/hospital/fall-prevention/toolkit/practices.html
      January 01, 2013 - Labor and Delivery Units Emergency Department Long Term Care Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures

4793. 3. Which fall prevention practices do you want to use? | Agency for Healthcare Research and Quality
      pcmh.ahrq.gov/patient-safety/settings/hospital/fall-prevention/toolkit/practices.html
      January 01, 2013 - Labor and Delivery Units Emergency Department Long Term Care Ambulatory Care End-Stage … Renal Disease (ESRD) Clinics Pharmacy Multiple Settings Quality Measures

4794. Screening Asymptomatic Adults With Resting or Exercise Electrocardiography: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/-RCaAaDL6hY8SrAwmmPa5X
      September 01, 2011 - Ann Intern Med. 2011;155:375-385. www.annals.org For author affiliations, see end of text. … statin use CHD events: 4.0% CVD events: 1.7% Good Diercks et al, 2002 (31) Prevention of Renal … and Vascular End- stage Disease study The Netherlands General community n=7,330 Mean age: 48 … rest to peak exercise: Continuous outcome Ratio of heart rate to metabolic reserve used by stage

4795. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
      December 31, 2013 - pioglitazone at baseline (228 mg/dl), and for placebo plus pioglitazone at baseline (236 mg/dl) and end … No clinically significant changes in renal function. … Glimepiride(sulfo nylureas) with metformin RCT 68 normoalbuminuric type 2 diabetes patients 1 year Renal … A total of 39.2 (exenatide) vs. 20.8% (insulin) of patients reached the composite end point of A1C … Yale, 201345 Canagliflozin Placebo RCT 269 subjects with type 2 diabetes and stage 3 chronic kidney

4796. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
      effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
      December 31, 2013 - pioglitazone at baseline (228 mg/dl), and for placebo plus pioglitazone at baseline (236 mg/dl) and end … No clinically significant changes in renal function. … Glimepiride(sulfo nylureas) with metformin RCT 68 normoalbuminuric type 2 diabetes patients 1 year Renal … A total of 39.2 (exenatide) vs. 20.8% (insulin) of patients reached the composite end point of A1C … Yale, 201345 Canagliflozin Placebo RCT 269 subjects with type 2 diabetes and stage 3 chronic kidney

4797. Making Healthcare Safer Practices: 15. Care Transitions (pdf file)
      ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/care-transitions-1.pdf
      March 01, 2020 - Evaluation of BOOST implementation in the second cohort of hospitals occurred via mid-year and end-year … common chronic illnesses (i.e., all primary diagnoses except neurological disorders or cancer, end-stage … renal disease, and untreated psychiatric disorders) in Aetna’s Medicare Advantage program in the

4798. Making Healthcare Safer Practices: 15. Care Transitions (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/care-transitions-1.pdf
      March 01, 2020 - Evaluation of BOOST implementation in the second cohort of hospitals occurred via mid-year and end-year … common chronic illnesses (i.e., all primary diagnoses except neurological disorders or cancer, end-stage … renal disease, and untreated psychiatric disorders) in Aetna’s Medicare Advantage program in the

4799. Research Findings #12: Health Care Expenses in the United States, 1996 (pdf file)
      meps.ahrq.gov/data_files/publications/rf12/rf12updt.pdf
      December 01, 2000 - The 1996 MEPS NHC sample was selected using a two-stage stratified probability design. … In the first stage, facilities were selected; in the second stage, facility residents were sampled, selecting … At the end of three rounds of data collection, the sample consisted of 815 responding facilities, 3,209 … plan for the elderly, persons receiving Social Security disability payments, and most persons with end-stage … renal disease.

4800. Research Findings #12: Health Care Expenses in the United States, 1996 (pdf file)
      meps.ahrq.gov/data_files/publications/rf12/rf12.pdf
      December 01, 2000 - The 1996 MEPS NHC sample was selected using a two-stage stratified probability design. … In the first stage, facilities were selected; in the second stage, facility residents were sampled, selecting … At the end of three rounds of data collection, the sample consisted of 815 responding facilities, 3,209 … plan for the elderly, persons receiving Social Security disability payments, and most persons with end-stage … renal disease.